BTNL2 and neoplasm: We then re-implanted A20 tumour in the contralateral flank of these mice and failed to detect any evidence of tumour engraftment after re-implantation, indicating the development of long-term anti-tumour immune memory in response to treatment with anti-BTNL2 mAb (Fig. 1d).